Regulatory Roundup: Week of July 13, 2026 — NRC Proposes First Radiation Overhaul Since 1991

ByEduardo Bacci

July 17, 2026
Aerial view of the United States Capitol building in Washington, D.C.United States Capitol Building, Washington, D.C. Aerial. The United States Capitol is the meeting place of the United States Congress, the legislature of the Federal government of the United States. Located in Washington, D.C., it sits atop Capitol Hill at the eastern end of the National Mall.

Federal agencies filed a dense slate of rulemakings during the week of July 13, 2026, ranging from the Nuclear Regulatory Commission’s first comprehensive rewrite of its radiation-protection standards in more than three decades to a pair of presidential proclamations reshaping trade posture and environmental compliance for domestic manufacturers. The Federal Register’s July 16 edition alone carried 16 rules and six proposed rules drawn from 44 agencies, according to the publication’s daily summary.

This roundup tracks nine of the week’s most consequential actions, with comment deadlines, available economic estimates, and links to the underlying records. Several proposals carry near-term comment deadlines — including a July 23 cutoff for the largest federal procurement rewrite in a generation — that businesses, trade associations, and public commenters will want to calendar.

1. NRC proposes first radiation-protection overhaul since 1991

The Nuclear Regulatory Commission on July 15 published a proposed rule, “Reforming and Modernizing the NRC’s Radiation Protection Framework,” that would amend the agency’s core standards for protection against radiation for the first time since the last major revision in 1991. According to the notice, the revisions respond to Section 5(b) of Executive Order 14300, “Ordering the Reform of the Nuclear Regulatory Commission,” and would reflect developments in the field of radiation protection over the intervening 35 years.

The filing indicates the Commission is weighing changes to occupational dose limits, public dose limits, and the dose-based acceptance criteria used to evaluate design-basis accidents, citing scientific work including recommendations from the National Council on Radiation Protection and Measurements. The NRC is also releasing draft implementing guidance for comment alongside the rule.

Comments are due by 11:59 p.m. Eastern on August 31, 2026, under Docket ID NRC-2025-1140. Because the framework governs licensees across the commercial nuclear, medical, and industrial sectors, the proposal is likely to draw extensive technical comment before any final rule is issued.

2. Section 232 proclamation targets aircraft and jet-engine imports

A presidential proclamation published July 15, “Adjusting Imports of Commercial Aircraft, Jet Engines, and Aircraft and Engine Parts Into the United States” (Proclamation 11040 of July 9, 2026; 91 FR 43507), concurs with a Commerce Department finding under Section 232 of the Trade Expansion Act of 1962 that imports of aircraft, engines, and parts “threaten to impair the national security of the United States.”

Notably, the document states the Secretary of Commerce recommended that no immediate tariffs be imposed. Instead, the proclamation directs the Secretary and the U.S. Trade Representative to pursue negotiated agreements with trading partners and to report on progress within 180 days. The text cites counterfeit and non-compliant foreign parts, supply-chain concentration, and erosion of the domestic aerospace workforce as national-security concerns.

The measure leaves open the possibility of “alternative remedies,” including tariffs, should negotiations stall — a posture that industry filings suggest keeps leverage in reserve while avoiding an immediate cost shock to carriers and manufacturers dependent on global supply chains.

3. Chemical-manufacturing proclamation grants two-year Clean Air Act exemption

A second proclamation, published July 16 (Proclamation 11041 of July 9, 2026; 91 FR 44719), exempts certain stationary sources from compliance with portions of the Environmental Protection Agency’s 2024 “HON Rule” (89 FR 42932) for two years beyond the rule’s compliance deadlines. The exemption is issued under Section 112(i)(4) of the Clean Air Act, which permits the president to grant relief on national-security grounds.

The proclamation determines that the control technology required by the HON Rule “does not exist in a commercially viable form” sufficient to meet the deadlines, and that continued domestic chemical production is a national-security interest. Facilities listed in the proclamation’s Annex I will remain subject to the emissions standards that applied before the HON Rule during the two-year window.

The action is one of the week’s clearest examples of deregulatory relief. Public-health and environmental groups have historically opposed such exemptions from hazardous-air-pollutant standards; the proclamation itself does not open a comment period, as it is a presidential document rather than an agency rulemaking.

4. FAR Council advances “revolutionary” procurement overhaul — comment closes July 23

The Federal Acquisition Regulatory Council — comprising the Office of Federal Procurement Policy, the Defense Department, GSA, and NASA — is midway through what filings describe as a complete rewrite of the Federal Acquisition Regulation. The proposed rule revising FAR Parts 1, 2, 4, 33, 39, 40, 52, and 53 (RIN 9000-AO86) implements Executive Order 14275, “Restoring Common Sense to Federal Procurement.”

According to the summary, the FAR Council is issuing twelve proposed rules that “collectively will streamline the FAR in its entirety,” directing the elimination of what the order calls excessive acquisition regulations. The filings emphasize fiscal responsibility, price preferences for domestically sourced goods under “Buy American” authorities, and faster acquisition timelines.

The comment window on this tranche closes July 23, 2026 — the most immediate deadline in this week’s roundup. Given the FAR’s reach across every federal contract, contractor associations are expected to file heavily before the cutoff.

5. FDA proposes registration relief for distributed and foreign drug makers

The Food and Drug Administration on July 13 proposed to amend drug establishment registration and listing requirements (RIN 0910-AI94). The rule would let a “distributed manufacturing” operation that makes drugs at multiple physical sites register as a single establishment, and would align rules for foreign establishments with the PREVENT Pandemics Act.

In its regulatory-flexibility analysis, the FDA proposes to certify that the rule “will not have a significant economic impact on a substantial number of small entities,” reasoning that it imposes no costs beyond the time to read revisions to an existing regulation. The agency proposes an effective date 30 days after any final rule.

Comments are due September 11, 2026. The proposal is a modernization measure aimed at newer manufacturing models, including point-of-care and continuous manufacturing that were not contemplated when the registration framework was written.

6. Rail-safety rollback: FRA extends comment period on rescinding signal-employee certification

The Federal Railroad Administration on July 14 extended the comment period on its May 15 proposal (2026-09792) to rescind the 2024 final rule requiring certification of railroad signal employees. The Brotherhood of Railroad Signalmen petitioned July 1 for a 60-day extension; the FRA partially granted the request, pushing the deadline to August 13, 2026, under Docket FRA-2022-0020.

The union stated it needed additional time to evaluate the operational and safety impacts of rescinding the rule. A companion notice the same day similarly extended the comment period on a proposal to rescind dispatcher certification requirements.

The two rescissions are among the more contested deregulatory items on the current docket. Labor organizations have publicly urged the FRA to retain the certification programs, while the agency’s proposals frame them as duplicative of existing training requirements. No final action has been taken; both remain open for comment.

7. FTC seeks renewal of Magnuson-Moss dispute-settlement paperwork clearance

The Federal Trade Commission published a July 13 information-collection notice seeking to extend, for three years, the Office of Management and Budget clearance for its Informal Dispute Settlement Procedures Rule under the Magnuson-Moss Warranty Act (16 CFR Part 703). The current clearance expires July 31, 2026.

The notice provides a concrete cost estimate: an estimated 11,738 annual burden hours and roughly $339,836 in estimated annual labor costs for affected warrantors that operate informal dispute-resolution mechanisms. The FTC reported that an April 17 request for comment drew no germane responses.

Comments are due August 12, 2026. While a routine Paperwork Reduction Act renewal, the filing is a useful data point on the compliance burden the warranty-dispute framework places on business.

8. President continues transnational-crime national emergency

Among the week’s presidential documents, a July 16 notice continued the national emergency with respect to significant transnational criminal organizations, originally declared under Executive Order 13581 in 2011. The continuation keeps in force the associated blocking sanctions authorities administered by the Treasury Department’s Office of Foreign Assets Control.

Such annual continuations are procedural under the National Emergencies Act, which requires renewal to prevent automatic termination. The notice does not by itself add designations, but it preserves the legal architecture under which OFAC issues sanctions actions — several of which appeared in the same week’s Federal Register notices.

9. Housekeeping rules: civil-penalty inflation adjustments and state air-plan approvals

Several lower-profile but legally binding actions also cleared this week. Multiple agencies issued annual inflation adjustments to civil monetary penalties, including the Federal Housing Finance Agency’s civil money penalty adjustment required under the Federal Civil Penalties Inflation Adjustment Act. These recalibrations raise maximum penalty amounts across a range of statutes and take effect without a comment period.

On the environmental side, the EPA finalized several state implementation plan actions on July 15, including approvals addressing Missouri controls on nitrogen-oxide emissions from large stationary engines and source-specific plans for power plants in New York and Wisconsin. Though state-level in origin, SIP approvals carry federal enforceability and illustrate how national air-quality standards are implemented locally.

Relevance to TIJ beats and what to watch

For accountability-focused readers, several threads bear watching. The FAR overhaul and the FRA rescissions are the clearest tests of the administration’s deregulatory agenda, and both invite scrutiny of whether streamlining preserves oversight and safety guarantees; the FRA docket in particular pits agency cost-cutting against organized labor’s safety objections. The chemical-manufacturing exemption raises the recurring question of how national-security justifications interact with environmental compliance — a legal theory likely to be litigated.

On the money-and-markets beat, the Section 232 aircraft proclamation signals a negotiate-first trade posture that stops short of tariffs for now, while the FTC and civil-penalty filings quantify compliance costs that ultimately reach consumers and firms. Readers tracking the regulatory pipeline can monitor pending significant rules and their cost-benefit review status through the Office of Information and Regulatory Affairs dashboard at Reginfo.gov, and can review or comment on any of the above through the primary records linked here and at Regulations.gov.

Comment deadlines this cycle: Federal Acquisition Regulation overhaul — July 23; FTC Magnuson-Moss information collection — August 12; FRA signal-employee and dispatcher certification rescissions — August 13; NRC radiation-protection framework — August 31; FDA drug-establishment registration — September 11.

All figures and characterizations in this report are drawn from primary Federal Register records and official agency filings linked above. Proposed rules are distinguished from final actions; pending proposals remain subject to public comment and are not final agency decisions.

ByEduardo Bacci

Investigative journalist and founder of The Investigative Journal. Specializing in OSINT-driven reporting on corporate malfeasance, government accountability, and institutional corruption.